Shardul Amarchand Mangaldas & Co advises Evonile Pharma Ltd. on acquisition of ‘Minipress’ and ‘Minipres’ brands from Pfizer
SAM advised Evonile Pharma Limited on all aspects of the transaction.
Pfizer
Federal Court of Canada upholds validity of Pfizer’s pneumococcal vaccine patents; Two Formulation patents held invalid
Federal Court of Canada: The Bench of Gagné, Associate CJ., upheld the validity of one pneumococcal vaccine patents pertaining to Prevnar 13
Subject Expert Committee (SEC) meets to consider Emergency Use Authorisation request from Pfizer, SII and Bharat Biotech
The Subject Expert Committee (SEC) in the Central Drugs Standard Control Organisation (CDSCO) to consider the Emergency Use Authorisation (EUA) request of
Pfizer to combine off-patent drug business with Mylan
As reported by CNBC, Pfizer is set to combine its off-patent drug business with Mylan– a generic drugmaker. Pfizer shareholders would own